Keybanc Maintains Overweight on American Healthcares, Raises Price Target to $28
Portfolio Pulse from Benzinga Newsdesk
Keybanc analyst Austin Wurschmidt has maintained an Overweight rating on American Healthcares (NYSE:AHR) and raised the price target from $27 to $28.
September 20, 2024 | 11:07 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Keybanc analyst Austin Wurschmidt has maintained an Overweight rating on American Healthcares and increased the price target from $27 to $28, indicating a positive outlook.
The increase in price target from $27 to $28 by Keybanc suggests a positive outlook for American Healthcares. Maintaining an Overweight rating indicates confidence in the stock's performance, likely leading to a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100